Desjardins Global Asset Management’s Biogen BIIB Stock Holding History

Desjardins Global Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$115K	Sell	446 -2,750	-86%	-$675K	0.01%	447
2023 Q3	$821K	Buy	3,196 +575	+22%	+$154K	0.09%	193
2023 Q2	$747K	Buy	2,621 +955	+57%	+$284K	0.09%	225
2023 Q1	$463K	Buy	1,666 +476	+40%	+$132K	0.06%	265
2022 Q4	$329K	Buy	1,190 +785	+194%	+$222K	0.05%	285
2022 Q3	$108K	Hold	405	–	–	0.01%	385
2022 Q2	$82K	Sell	405 -28	-6%	-$5.72K	0.01%	397
2022 Q1	$91K	Sell	433 -26	-6%	-$5.65K	0.01%	389
2021 Q4	$110K	Buy	+459	New	+$118K	0.01%	399

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Desjardins Global Asset Management's BIIB Position: Q4 2023 in Review

Desjardins Global Asset Management reduced its Biogen (BIIB) stake by 86% in Q4 2023, selling an estimated $675K and leaving 446 shares worth $115K. The position accounts for 0.01% of the portfolio, ranked #447.

Desjardins Global Asset Management first reported a position in BIIB in Q4 2021 and has held it in 9 quarters since. The position peaked at $821K in Q3 2023. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q4 2023.

Desjardins Global Asset Management held 446 shares of Biogen worth $115K as of Q4 2023.
Desjardins Global Asset Management sold 2,750 Biogen shares in Q4 2023, an estimated $675K.
Biogen made up 0.01% of Desjardins Global Asset Management's portfolio in Q4 2023, its #447 holding.
Desjardins Global Asset Management first reported a position in Biogen in Q4 2021 and has held it in 9 quarters since.
Desjardins Global Asset Management's Biogen position peaked at $821K in Q3 2023.
1,002 funds tracked by Wall St. Rank held Biogen as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.